DES cancer lawsuit targets drug companies

BOSTON – Fifty-three women around the nation are suing the drug companies who made and promoted a synthetic estrogen known as DES, or diethylstilbestrol, claiming it resulted in their developing breast cancer. More
This item is available in full to subscribers. If you are a current subscriber, log in to continue.

Otherwise, purchase a subscription to continue.

You can also purchase this single article, if you prefer. Click here to continue.
Calendar
PBN Hosted
Events

Celebrate RI's many exceptional women at PBN's Business Women Awards luncheon May 30th at the Providence Marriott. Reserve your seat today!
Advertisement
National
Local
Latest News